Phase 3 Trial Demonstrates Superior Patient Treatment Convenience of MC2-01 Calcipotriene Plus Betamethasone Dipropionate Cream Compared to Current Topical Suspension. J of Skin 2020, 4 (5), s62. https://doi.org/10.25251/skin.4.supp.61.